🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchOrforglipron ATTAIN-4 — my results so far Page 6

Orforglipron ATTAIN-4 — my results so far

roxy_nash Wed, Apr 16, 2025 at 6:46 AM 43 replies 2,076 viewsPage 6 of 9
tony_orlando
Member
234
1,123
Nov 2024
Orlando, FL
Apr 16, 2025 at 3:16 PM#26

Yep. My endo said the same thing about Orforglipron.

17 2NauseaFreeNow, SteveThurs, B12Beth and 14 others
Reply Quote Save Share Report
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Apr 16, 2025 at 3:33 PM#27

+1 to NauseaFreeNow. Especially the point about "Follow-up question: did you change anyth..." — I have seen the same in my own experience with Orforglipron ATTAIN-4 my.

29 19PedsEndoPhilly, SleepDoc_PDX, RegAffairsDC and 26 others
Reply Quote Save Share Report
A1cHero_PHX
Member
523
2,678
Jul 2024
Phoenix, AZ
Apr 16, 2025 at 3:50 PM#28

Can confirm — my data shows the same pattern.

50 6tampaLisa73, KarenAZ_mom, zoe_NC and 47 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Apr 16, 2025 at 4:07 PM#29

+1 to PeptideChemSF. Especially the point about "The first 6 weeks are the hardest..." — I have seen the same in my own experience with Orforglipron ATTAIN-4 my.

21 11PurityPaulOR, MaxMetOK, MounjBrad and 18 others
Reply Quote Save Share Report
JakeBK_lifts
Member
523
2,345
Jul 2024
Brooklyn, NY
Apr 16, 2025 at 4:24 PM#30

Subscribing to this thread. Orforglipron ATTAIN-4 my is exactly what I've been researching. 🙏

28 2DataDave, Dr.GutHealth, amsterdam_pete and 25 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register